Brain bleed surgery trial using endoscope for deep brain bleeding
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether a minimally invasive brain surgery using an endoscope can improve outcomes for people with a deep brain bleed. It also studies the safety of this approach compared with standard care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 to 80, and you can be of any sex.
- A CT scan confirmed the bleed within 24 hours of symptom onset (or last-known good time).
- The bleed is in a “deep” part of the brain (like the internal/external capsule or putamen) and the bleed size is at least 25 mL.
- The bleed must be stable on repeat CT scans, with a plan to re-scan if it enlarges.
- You need to be in the right time window: randomization is within 24 hours after the first CT, and surgery (if assigned) happens within 6 hours after randomization (up to 54 hours after onset).
- Your prior functioning was good (modified Rankin Scale 0–1) and your blood pressure is controlled to 180 or less.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combination approach—using a scope through a small skull opening to remove the clot from a deep brain bleed (basal ganglia), then giving a steroid called methylprednisolone to reduce inflammation. It may help people with a moderate-sized bleed who get treated within 24 hours.
This trial tests a minimally invasive surgery to remove blood clots deep in the brain after a spontaneous bleed. It may help patients with moderate to large bleeds who are at least 18 and up to 80 years old.
This trial tests a type of keyhole surgery called neuroendoscopic surgery to remove large blood clots in the brain. It may help people who have had a serious brain bleed and need urgent surgery.
This trial tests a procedure that uses a small camera to remove the blood clot from the brain, combined with a steroid medication, to reduce damage from a brain bleed. It may be an option for people with a moderate-to-large brain bleed in the outer part of the brain who can be treated within 24 hours.
This trial tests a minimally invasive surgery to remove blood clots deep in the brain caused by spontaneous bleeding. It aims to improve recovery for patients who meet specific criteria, such as clot size and time since symptoms started.
This trial studies whether a minimally invasive, image-guided endoscopic procedure can remove blood after a specific type of brain bleed. It may help reduce symptoms and improve outcomes compared with standard care, but you must meet timing and medical criteria.
Hear when a new Intracerebral Hemorrhage Basal Ganglia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.